Orphazyme CFO to take up CEO mantle ahead of time

Anders Vadsholt, the current CFO of biotech company Orphazyme, will become the company’s CEO on Tuesday, one month earlier than previously announced.
Photo: Orphazyme / PR
Photo: Orphazyme / PR
by CHRISTOPHER DUE KARLSSON, translated by daniel pedersen

From Tuesday, biotech company Orphazyme’s current CFO, Anders Vadsholt, will be the company’s CEO.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading